---------- Forwarded message ---------
From: Chris De Graaf <Chris.DeGraaf@soseiheptares.com>
Date: Wed, Feb 6, 2019 at 3:01 PM
Subject: Ultra-large library docking + ad Principal Scientist Computational Chemistry - Sosei Heptares
To: bshoichet@gmail.com <bshoichet@gmail.com>
From: Chris De Graaf <Chris.DeGraaf@soseiheptares.com>
Date: Wed, Feb 6, 2019 at 3:01 PM
Subject: Ultra-large library docking + ad Principal Scientist Computational Chemistry - Sosei Heptares
To: bshoichet@gmail.com <bshoichet@gmail.com>
Dear Brian,
I hope you are doing well, congratulations on amongst others your recent impressive publication on ultra-large library docking!
Attached/link to a Principal Scientist in Computational Chemistry position at Sosei Heptares, I would be great full if you could share this with those interested:
Many thanks in advance and with kind regards,
Chris
Chris De Graaf PhD
Director, Computational Chemistry
| d | +44 (0)1223 949210 |
| m | +44 (0)7731 082157 |
| e | Chris.DeGraaf@SoseiHeptares.com |
Steinmetz Building
Granta Park
Cambridge
CB21 6DG
United Kingdom
The information in this e-mail is confidential and may be legally privileged. It is intended for the exclusive attention of the addressee stated above and should not be copied or disclosed to any other. If you have received this transmission in error, please contact the sender immediately, make no use of its contents and delete this message from your system. Contact and registered office address: Heptares Therapeutics Limited, Granta Park, Great Abington, Cambridge, CB21 6DG. Company No: 06267989.